• KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  • KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  • KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

NEWS

The world of Kedrion Biopharma at a glance:
discover the latest
up-to-date news.

Read All the News
25-08-2023
Kedrion attended the 75th Annual Bleeding Disorders Conference in the US
The company supported the Plasminogen Deficiency Foundation in a round-table for patients with Congenital Plasminogen Deficiency
Read all
07-08-2023
Kedrion supports the IDF Research Grant Program for the second year
The Program encourages and supports patient-oriented research on Primary Immunodeficiencies
Read all
13-07-2023
Kedrion confirms its commitment against Rabies infections in the US
Distribution agreement with Kamada for KEDRAB® extended until March 2026
Read all
2022 Annual Report
Pharmacovigilance
Medical & Scientific Information
JOIN RARE DISEASE DAY